Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Atlatl Advisers LLC Purchases New Shares in Astera Labs, Inc. $ALAB

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Atlatl Advisers acquired 11,271 Astera Labs shares worth approximately $4.0 million during the third quarter. Institutional investors collectively own 60.47% of the company.
  • Astera Labs exceeded quarterly expectations with $0.80 in EPS versus the $0.69 consensus estimate and revenue of $392.4 million, up 104.5% year over year.
  • Analysts maintain a “Moderate Buy” consensus with an average price target of $340.79, although some firms recently downgraded the stock. Insiders have sold 408,558 shares worth $127.3 million over the past 90 days.
  • Want to know the moment analysts change their view on Astera Labs? Get MarketBeat All Access for $149 a year and keep that rate for life.

Atlatl Advisers LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 11,271 shares of the company's stock, valued at approximately $4,012,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. purchased a new stake in Astera Labs during the second quarter valued at $6,609,581,000. Atreides Management LP lifted its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. Van ECK Associates Corp lifted its position in Astera Labs by 20.0% during the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock valued at $1,080,980,000 after purchasing an additional 373,545 shares during the last quarter. Bank of America Corp DE bought a new position in Astera Labs during the second quarter valued at $1,061,791,000. Finally, Amundi grew its stake in shares of Astera Labs by 77.9% in the 1st quarter. Amundi now owns 1,880,830 shares of the company's stock worth $206,139,000 after buying an additional 823,477 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Stock Down 0.3%

ALAB stock opened at $257.16 on Friday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The stock has a market capitalization of $44.61 billion, a price-to-earnings ratio of 127.31 and a beta of 3.68. The firm's fifty day simple moving average is $310.54 and its two-hundred day simple moving average is $302.78.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm's revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 2.71 EPS for the current year.

Insider Activity

In other news, Director Stefan Dyckerhoff sold 8,994 shares of the company's stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the transaction, the director owned 3,309 shares of the company's stock, valued at approximately $909,842.64. This represents a 73.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Jefferies Financial Group boosted their target price on shares of Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. Northland Securities downgraded shares of Astera Labs from an "outperform" rating to a "market perform" rating in a report on Friday, October 9th. Zacks Research lowered Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 5th. Royal Bank Of Canada lifted their price target on Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 5th. Finally, Morgan Stanley boosted their price objective on Astera Labs from $240.00 to $335.00 and gave the stock an "overweight" rating in a research note on Monday, August 3rd. Twelve equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $340.79.

Get Our Latest Report on Astera Labs

About Astera Labs

(Free Report)

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

Further Reading

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines